Seattle Biotech Kineta gets NIH grant for virus drugs

Known as a vector for the West Nile virus, this Culex quinquefasciatus mosquito has landed on a human finger. Biotechnology company Kineta Inc. said it received a $2.8 million federal grant to develop new antiviral drugs aimed at hepatitis, ... Seattle Biotech Kineta gets NIH grant for virus drugs